American Conference Institute (ACI) will be holding its 16th Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions from February 27-29, 2012 in New York, NY. The conference will allow attendees to:
• Incorporate the right takeaways from the recently enacted America Invents Act into business development strategies;
• Negotiate creative deal terms that provide for greater leveraging of risks;
• Understand what savvy buyers look for in M&A or product licensing and how sellers can best position assets;
• Uncover hidden challenges that may negatively impact the value of acquired IP;
• Structure profitable public-private deals; and
• Build strategic end value into your agreements.
In particular, ACI's faculty will offer presentations on the following topics:
• What the America Invents Act means for deal makers and business development strategies;
• Identifying IP red flags that impact the value and success of a life sciences transaction;
• Deciphering alternative business models to select the best deal structure in a time of changing industry dynamics;
• Preparing your IP for M&A or product license: What savvy buyers look for;
• Partner selection for facilitating product development and maximizing commercial returns;
• Opening doors to new markets and products with strategic alliances;
• Bayh-Dole after Stanford: Revising research agreements with academic institutions;
• Exploring perspectives of innovative small companies on the industry's prospects for 2012 and beyond;
• Bridging gaps between buyers and sellers: Finding the right valuation and closing the deal;
• Overcoming negotiating hurdles in developing profitable public-private deals;
• "No regrets" drafting: Terms to include at the onset that facilitate product commercialization and profitable cooperation between partners; and
• Building strategic end value into your agreement.
A post-conference master class, entitled "Life Sciences IP Due Diligence Boot Camp," will be offered from 9:00 am to 3:30 pm on February 29, 2012. In this workshop, ACI faculty will offer presentations on the following topics:
• Understanding and contrasting the different and changing metrics for M&A;
• Mitigating global antitrust and other legal risks presented in life sciences M&A;
• Creating a practical and useful checklist that incorporates both the business objectives of the deal and a comprehensive IP assessment;
• Resolving ownership rights and inventorship issues arising under the target's prior contractual, third party and licensing obligations which could impact your deal; and
• Ethical considerations in protecting privileged documents and confidential information.
The agenda for the Life Sciences Collaborative Agreements and Acquisitions conference can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee for the conference is $2,295 (conference alone), $3,095 (conference and master class), or $1,395 (master class alone). Those registering by January 13, 2012 will receive a $300 discount off the conference alone or conference and master class, and those registering by February 3, 2012 will receive a $200 discount off the conference alone or conference and master class. In addition, Patent Docs readers who reference the discount code "PD 200" will receive $200 off the current price tier when registering. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media partner of ACI's Life Sciences Collaborative Agreements and Acquisitions conference.
Comments